No profile data available.
Revelation Biosciences, Inc. (REVB) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in San Diego, United States, with about 8 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$14.87 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $3.03 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Revelation Biosciences reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$3.03 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include For The Earth Corp. (FTEG), Bhang Inc. (BHNGF), Eagle Pharmaceuticals, Inc. (EGRX), Weed, Inc. (BUDZ).